Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Head and Neck Neoplasms 2103 Squamous Cell Carcinoma of Head and Neck 1654 Nasopharyngeal Carcinoma 517 Thyroid Neoplasms 478 Carcinoma, Non-Small-Cell Lung 438 Breast Neoplasms 315 Mouth Neoplasms 312 Neoplasms 309 Melanoma 299 Oropharyngeal Neoplasms 285 Colorectal Neoplasms 274 Lung Neoplasms 248 Carcinoma, Squamous Cell 240 Neoplasm Metastasis 235 Ovarian Neoplasms 228 Uterine Cervical Neoplasms 204 Stomach Neoplasms 195 Salivary Gland Neoplasms 192 Laryngeal Neoplasms 192 Nasopharyngeal Neoplasms 189 Carcinoma, Renal Cell 183 Esophageal Neoplasms 179 Pancreatic Neoplasms 176 Prostatic Neoplasms 158 Sarcoma 142 Triple Negative Breast Neoplasms 136 Urinary Bladder Neoplasms 135 Recurrence 128 Endometrial Neoplasms 124 Hypopharyngeal Neoplasms 121

Interventions

lenvatinib 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thyroid Cancer Metastatic × Head & Neck × Clear all

NCT03732495 2022-03-29

LENVOS

Centre Leon Berard

Phase 2 Unknown

EndocrineHead & Neck

Thyroid Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡